Funding Links #4
| Scheme | Details | Typical timelines and budget |
| AZ Open Innovation | R&D challenges: specific challenges for which AZ seeks solutions. | As required to progress project |
| BHF Translational Award | Supports the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding: bridging the funding gap between promising innovations and the clinic | £750k. |
| CRUK Biotherapeutic Drug Discovery Programme Awards | Identify and characterise novel biotherapeutic targets. Identify and develop novel therapeutic entities for the benefit of cancer patients. |
Up to five years, £2.5M |
| CRUK Biotherapeutic Drug Discovery Project Awards | All stages of drug discovery, from target and pathway identification and validation, through to early preclinical studies. | One to three years, £100k p.a. |
| CRUK Innovation Prize | Develop the translational and commercial potential of research | One year, £50k |
| Innovate UK | Multiple schemes which are updated regularly, ranging from small innovation vouchers to large, collaborative programmes. Usually industry-led. | Various |
| MRC Biomedical catalyst | Early stage, small molecule, drug discovery. Will fund development of therapeutics. | Up to three years, £3M |
| Royal Society Paul Instrument Fund | For scientists in the UK who want to design and construct a novel instrument to measure phenomena in the physical sciences. | One to three years, £75k |
| Wellcome Trust Innovator Awards | For the development of healthcare innovations that could have a significant impact on human health. | Up to two years, £500k (£750k for multidisciplinary projects) |
| Worldwide Cancer Research | Funding for basic and translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer | 12-36 months, £250k |